Table 2

Hematologic response

ResponseImatinib resistant
Imatinib intolerant
Total
No.%No.%No.%
Cumulative response       
    Evaluable patients 199  88  287  
    Complete response 172 86 75 85 247 86 
Cumulative response among patients with no baseline complete hematologic response       
    Evaluable patients 100  41  141  
    Complete response 76 76 34 83 110 78 
Reason for exclusion from analysis       
    No baseline assessment 1  0  1  
ResponseImatinib resistant
Imatinib intolerant
Total
No.%No.%No.%
Cumulative response       
    Evaluable patients 199  88  287  
    Complete response 172 86 75 85 247 86 
Cumulative response among patients with no baseline complete hematologic response       
    Evaluable patients 100  41  141  
    Complete response 76 76 34 83 110 78 
Reason for exclusion from analysis       
    No baseline assessment 1  0  1  
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal